Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Business Update

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024


Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on March 5, 2024 at 8:30 a.m. ET to discuss fourth quarter and full year 2023 results and provide a general business update.

To access the conference call, please dial 800-715-9871 (domestic) or 646-307-1963 (international) and reference the conference ID number 4030622. To join the live webcast, please visit the "Investor and News" section of the Seres website at www.serestherapeutics.com.

A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for approximately 21 days.

About Seres Therapeutics

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres' lead program, VOWSTtm, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. Seres is evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation. For more information, please visit www.serestherapeutics.com.


These press releases may also interest you

at 12:25
Aldevron Announces Strategic Partnership with Acuitas Therapeutics
Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, today announced it has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company...

at 12:23
Repurchases of shares by EQT AB during week 19, 2024
Between 6 May 2024 and 10 May 2024 EQT AB (LEI code 213800U7P9GOIRKCTB34) ("EQT") has repurchased 348,028 own ordinary shares (ISIN: SE0012853455). The repurchases form part of the repurchase program of a maximum of 2,154,000 own ordinary shares...

at 12:20
NielsenIQ launches GenAI-based tool NIQ Ask Arthur into NIQ Discover empowering users to unlock the power of data
NielsenIQ (NIQ), the world leader in measurement and data analytics, is excited to announce that ?NIQ Ask Arthur'- a groundbreaking GenAI-driven tool?has been integrated into NIQ Discover. This transformative solution offers AI-guided global search...

at 12:10
Schools Hub Announces Release of AI-Powered Learning Solution Marketplace for Vocational Training
Schools Hub, the AI-powered, SaaS-based vocational learning management system (LMS), today announced the release of a new software platform that enables career coaches and others to amplify their online learning capabilities with individual schools...

at 12:05
CRN Recognizes Jill Kavalsky of Iron Bow on the 2024 Women of the Channel Power 100 Solution Provider List
Iron Bow Technologies, the next-generation technology solutions provider to government, commercial, and healthcare markets, announced today that CRN®, a brand of The Channel Company, has named Jill Kavalsky, Vice President of Strategic Alliances, as...

at 12:05
Eurofins EAG Laboratories Expands Battery Testing Services Supporting Client Acceleration of Battery Innovation
Eurofins EAG Laboratories, a global leader in materials testing services, is expanding its battery materials testing capabilities with a new purpose-built 6,600 square-foot laboratory located in Sunnyvale, CA. and expanded facilities at its Syracuse,...

More news about Science and technology...


News published on and distributed by: